Article Details
Retrieved on: 2018-04-24 11:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>... drugs like Cinryze, which treats hereditary angioedema; and Elaprase, a Hunter syndrome treatment, to Takeda's portfolio, and helps it tap into the lucrative market for orphan drugs, which treat rare diseases. The proposed deal is also the largest by a Japanese acquirer, topping <b>SoftBank Group</b> Corp.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here